(Q44071558)

29 November 2017

Effects of herbal components on cDNA-expressed cytochrome P450 enzyme catalytic activity (English)

1 reference

29 November 2017

L Zou

1

1 reference

29 November 2017

M R Harkey

series ordinal

2

1 reference

29 November 2017

G L Henderson

series ordinal

3

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 August 2002

1 reference

29 November 2017

11

1 reference

based on heuristic

inferred from page(s)

published in

Life Sciences

1 reference

29 November 2017

71

1 reference

29 November 2017

1579-1589

1 reference

29 November 2017

13

1 reference

Microtiter plate assays for inhibition of human, drug-metabolizing cytochromes P450

29 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901913-6

Effects of ginseng components on c-DNA-expressed cytochrome P450 enzyme catalytic activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901913-6

An in vitro evaluation of human cytochrome P450 3A4 inhibition by selected commercial herbal extracts and tinctures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901913-6

Variability in commercial ginseng products: an analysis of 25 preparations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901913-6

Effects of intrinsic fluorescence and quenching on fluorescence-based screening of natural products

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901913-6

Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901913-6

Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901913-6

Grapefruit juice and drugs. How significant is the interaction?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901913-6

The cardiac effects of terfenadine after inhibition of its metabolism by grapefruit juice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901913-6

Effect of grapefruit juice on carbamazepine bioavailability in patients with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901913-6

Influence of grapefruit juice on cisapride pharmacokinetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901913-6

Effect of grapefruit juice on pharmacokinetics and pharmacodynamics of verapamil enantiomers in healthy volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901913-6

Plasma concentrations of triazolam are increased by concomitant ingestion of grapefruit juice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901913-6

Interaction between grapefruit juice and midazolam in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901913-6

Dramatic inhibition of amiodarone metabolism induced by grapefruit juice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901913-6

Duration of effect of grapefruit juice on the pharmacokinetics of the CYP3A4 substrate simvastatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901913-6

Grapefruit juice inhibits 7-hydroxylation of coumarin in healthy volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901913-6

Grapefruit juice can increase the plasma concentrations of oral methylprednisolone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901913-6

St John's Wort: effect on CYP3A4 activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901913-6

St John's Wort induces intestinal P-glycoprotein/MDR1 and intestinal and hepatic CYP3A4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901913-6

St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901913-6

Indinavir concentrations and St John's wort.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901913-6

Acute heart transplant rejection due to Saint John's wort

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901913-6

Interaction of Hypericum perforatum (St. John's wort) with cyclosporin A metabolism in a patient after liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901913-6

Drug interaction of St John's wort with cyclosporin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901913-6

Drug interaction between St. John's wort and cyclosporine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901913-6

Pharmacokinetic interaction of digoxin with an herbal extract from St John's wort (Hypericum perforatum)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901913-6

St John's wort interaction with digoxin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901913-6

Effect of St. John's wort (Hypericum perforatum) on cytochrome P-450 2D6 and 3A4 activity in healthy volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901913-6

Lack of effect of St John's Wort on carbamazepine pharmacokinetics in healthy volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901913-6

Spontaneous bilateral subdural hematomas associated with chronic Ginkgo biloba ingestion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901913-6

Spontaneous hyphema associated with ingestion of Ginkgo biloba extract

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901913-6

Association of Ginkgo biloba with intracerebral hemorrhage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901913-6

Effect of a ginkgolide mixture (BN 52063) in antagonising skin and platelet responses to platelet activating factor in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901913-6

Coma in a patient with Alzheimer's disease taking low dose trazodone and gingko biloba

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901913-6

Coma from the health food store: interaction between kava and alprazolam

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901913-6

Positive interaction of ethanol and kava resin in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901913-6

Drug interactions and the cytochrome P450 system. The role of cytochrome P450 2C19.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901913-6

Cytochrome P4502C9: an enzyme of major importance in human drug metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901913-6

Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901913-6

Extensive binding of the bioflavonoid quercetin to human plasma proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901913-6

10.1016/S0024-3205(02)01913-6

7 January 2021

Identifiers

DOI

1 reference

29 November 2017

1 reference